Correlation Between Veracyte and Editas Medicine
Can any of the company-specific risk be diversified away by investing in both Veracyte and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Editas Medicine, you can compare the effects of market volatilities on Veracyte and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Editas Medicine.
Diversification Opportunities for Veracyte and Editas Medicine
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Veracyte and Editas is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Veracyte i.e., Veracyte and Editas Medicine go up and down completely randomly.
Pair Corralation between Veracyte and Editas Medicine
Given the investment horizon of 90 days Veracyte is expected to generate 0.51 times more return on investment than Editas Medicine. However, Veracyte is 1.98 times less risky than Editas Medicine. It trades about 0.13 of its potential returns per unit of risk. Editas Medicine is currently generating about -0.17 per unit of risk. If you would invest 3,380 in Veracyte on November 1, 2024 and sell it today you would earn a total of 1,064 from holding Veracyte or generate 31.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Veracyte vs. Editas Medicine
Performance |
| Timeline |
| Veracyte |
| Editas Medicine |
Veracyte and Editas Medicine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and Editas Medicine
The main advantage of trading using opposite Veracyte and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| Editas Medicine vs. Beam Therapeutics | Editas Medicine vs. Crispr Therapeutics AG | Editas Medicine vs. Caribou Biosciences | Editas Medicine vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |